Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermediate IND Severe Illness COVID-19 CP

NCT04411602 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT04411602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04411602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermediate IND Severe Illness COVID-19 CP
Lead sponsor
Henry Ford Health System
Phase
Phase 1
Overall status
Withdrawn
Start date
April 7, 2020
Completion date
April 7, 2021
Enrollment
0 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid, severe acute respiratory syndrome